Search for: "Daubert v. Merrell Dow Pharmaceuticals, Inc."
Results 121 - 140
of 248
Sorted by Relevance
|
Sort by Date
4 Mar 2012, 9:02 am
Merrill Dow Pharmaceuticals, Inc., 874 F.2d 307, 311-12 (5th Cir. 1989)(“Fortunately, we do not have to resolve any of the above questions [as to bias and confounding], since the studies presented to us incorporate the possibility of these factors by the use of a confidence interval.”) [read post]
17 Jan 2014, 8:27 pm
Merrell Dow Pharmaceuticals, Inc., the United States Supreme Court held for the first time that, to be admissible, scientific evidence must be both scientifically valid and properly applicable to the facts at issue in the case. [read post]
17 Mar 2014, 6:57 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
8 Jul 2010, 3:30 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
22 Feb 2011, 7:27 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), in analyzing the expert presentations relating to the Rule 23 requirements, Plaintiffs contend that the Ninth Circuit found this to be no abuse of discretion, and that it did not matter because the district court judge was "guided by Daubert," concluded that the expert opinions were "based on valid principles," and were "sufficiently probative" of the Rule 23 requirements. [read post]
27 Jul 2017, 2:00 am
MERRELL DOW PHARMACEUTICALS, INC 509 U.S. 579 (1993)KOKKONEN V. [read post]
25 Aug 2014, 10:23 pm
Merrell Dow Pharmaceuticals, Inc. (509 U.S. 579 [1993]).Admissibility of Accident Reconstruction Expert:Judge Timothy G. [read post]
4 Aug 2014, 2:13 pm
Merrell Dow Pharmaceuticals, Inc. (509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 [1993]), the Eleventh Circuit U.S. [read post]
17 Jan 2014, 8:27 pm
Merrell Dow Pharmaceuticals, Inc., the United States Supreme Court held for the first time that, to be admissible, scientific evidence must be both scientifically valid and properly applicable to the facts at issue in the case. [read post]
6 Apr 2016, 12:06 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), General Electric Co. v. [read post]
31 Dec 2009, 2:34 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), and its federal and state progeny. [read post]
25 Apr 2015, 11:03 am
The first edition of the Reference Manual on Scientific Evidence [Manual] was published in 1994, a year after the Supreme Court delivered its opinion in Daubert. [read post]
28 Jun 2012, 7:10 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
13 Nov 2018, 7:31 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993) (“Daubert”). [read post]
20 Dec 2017, 12:00 am
Merrell Dow Pharmaceuticals, Inc. [read post]
24 Feb 2017, 7:57 am
Merrell Dow Pharmaceuticals, Inc. [read post]
17 Oct 2015, 5:29 am
” Earp v. [read post]
21 Mar 2019, 4:00 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), which listed several factors that a court may consider when determining the admissibility of an expert. [read post]
10 Jun 2013, 4:15 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
13 Jun 2017, 4:00 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), where the Supreme Court ruled that, under the federal evidence rules, “the trial judge must ensure that any and all scientific testimony or evidence admitted is not only relevant, but reliable” in light of several factors enumerated by the Court. [read post]
